Conserved amino acid sequences within the L1 open reading frame of the human papillomavirus (HPV) genome were used as a basis to design two degenerate primers (GPI7 and GPI8) and one general probe (GPR22) which direct polymerase chain reaction (PCR) amplification and subsequent detection of a 620 to 660 bp DNA fragment. The conserved nature of the primers and probe was tested experimentally on a panel of 24 cloned HPV DNAs isolated from cutaneous and mucosal lesions, including HPV-2a and -57, which are known to be associated with lesions at both anatomical sites. The sensitivity of this PCR test was at the level of genomic Southern blot analysis, indicating that HPV infections producing high copy numbers can be detected. Positive results were obtained with DNA extracted from clinical samples of genital and cutaneous origin.
Conserved amino acid sequences within the L1 open reading frame of the human papillomavirus (HPV) genome were used as a basis to design two degenerate primers (GPI7 and GPI8) and one general probe (GPR22) which direct polymerase chain reaction (PCR) amplification and subsequent detection of a 620 to 660 bp DNA fragment. The conserved nature of the primers and probe was tested experimentally on a panel of 24 cloned HPV DNAs isolated from cutaneous and mucosal lesions, including HPV-2a and -57, which are known to be associated with lesions at both anatomical sites. The sensitivity of this PCR test was at the level of genomic Southern blot analysis, indicating that HPV infections producing high copy numbers can be detected. Positive results were obtained with DNA extracted from clinical samples of genital and cutaneous origin.
During the last decade it has become clear that the human papillomavirus (HPV) group is very heterogeneous at the DNA level. Based on liquid hybridization data, at least 60 different HPV genotypes have been identified and isolated from different lesions of epithelial origin . The association of certain HPV types with malignancies of the genital tract (Dfirst et al., 1983; Boshart et al., 1984) , skin (Orth, 1987) and aerodigestive tract (Kahn et al., 1986; Lindeberg et al., 1988) has been documented. Moreover, the involvement of unknown HPV types in squamous cell lesions has been postulated (de Villiers et al., 1985; Kahn et al,, 1986) .
The present method of isolating a new HPV type is based on the initial detection of HPV DNA by low stringency Southern blot analysis, probing with an isolated HPV genotype (Gissmann et al., 1982; Kahn et al., 1986) . This method, however, is hampered when putative distantly related HPV types lack sufficient homology with the genotype used as a probe. Polymerase chain reaction (PCR) amplification of part of the HPV genome would overcome this problem by generating a type-specific DNA fragment that could be used as a probe for high stringency analysis of genomic Southern blots and genomic libraries. Recently, a generalized PCR method for the detection of a broad spectrum of HPV genotypes using general or consensus primers has been introduced (Snijders et al., 1990; Manos et al., 1989; Gregoire et al., 1989) . The sequenced HPV genotypes do not show nucleotide sequence identity over a length of more than 12 bases (Gregoire et al., 1989) , so the primers or the method used have had to be adapted to ensure the detection of at least a subset of the sequenced genotypes and related HPV DNAs. The difference at the nucleotide level between the sequenced HPV types associated with cutaneous and mucosal lesions has forced us to design two general primer pairs, one specific for 'cutaneous' HPV types and one for 'mucosotropic' HPV types (Snijders et al., 1990) . However, the finding that some types, including the related types HPV-2a and -57, show both a cutaneous and mucosal tropism indicates that there are exceptions to the rule that cutaneous and musocotropic HPV types form distinct groups . The existence of additional HPV types showing such ambivalent tropism can not be excluded and 'cutaneous-like' HPV types present in mucosal lesions could be missed by general primers selected for mucosotropic HPV types. In this study, a new, generalized HPV PCR assay was developed which makes use of highly degenerate primers and a probe, containing more than one base at a certain position, that were designed to cover all possible base combinations encoding a certain amino acid (Mack & Sninsky, 1988; Gould et al., 1989) 
3'-GTY CCN GTR TTR TTR CCN YAcctagggc-5' Three short regions were found within the LI ORF which exhibited amino acid conservation over at least six codons and could be used to design HPV-specific general primers and an oligonucleotide probe. In the first region selected, all PVs share the sequence Arg-Gly-Gln-ProLeu-Gly, whereas, with the exception of HPV-8, the HPVs share the sequence Gly-Arg-Gly-Gln-Pro-LeuGly (Fig. I a) . In the second region all the PVs have the sequence Gln-Gly-His/Met/Gln-Asn-Asn-Gly, whereas the HPVs share the sequence Gln-Gly-His-Asn-AsnGly, except HPV-la which differs at position 3 (Fig. 1 b) . Comparison of sequences in the third region yielded a
consensus for the PVs of Asp-Gly-Asp-Met-X-Asp/GluThr/Ile-Gly-Phe/Tyr-Gly, and Asp-Gly-Asp-Met-Val/ Ala/Ile-Asp/Glu-Thr/Ile-Gly-Phe/Tyr-Gly for the HPVs, except HPV-16 which differs at position 6. Based on the sequence conservation in these regions of the HPVs a highly degenerate forward primer, GP17 (Fig.  la) , backward primer, GP18 (Fig. lb) , and general oligonucleotide probe, GPR22 (5' ARGAYGGN-
, where Y is CorT, Ris A or G, W is AorT, and N isA, G, C orT), were designed; these include most of the nucleotides of the sequenced HPVs and all the additional codons specifying amino acids conserved amongst the HPVs. The oligonucleotide probe GPR22 spans nucleotides 6223 to 6253 of the HPV-16 genome (Seedorfet al., 1985) and corresponding sequences of the equivalent region of all the PVs examined. To reduce the degree of degeneracy of the primers and probe, single nucleotide differences producing a codon different to those conserved in the majority of HPVs were not included. Consequently, GP17 shows one mismatch with the HPV-8 sequence (Fig. 1 a) , GP18 one mismatch with the HPV-la sequence (Fig. 1 b) and GPR22 one mismatch with the HPV-16 sequence. For the same reason, sequences that seemed to be specific for animal PVs (e.g. amino acid position 3 of the GP18 sequence, as shown in Fig. 1 b) were also not included in primers and probe. As has been determined recently (Sommer & Tautz, 1989; Snijders et al., 1990) , sequences with limited mismatches can be used in the PCR, allowing successful amplification of target DNA with only one or a few base differences. To facilitate eventual cloning and to stabilize the primer-template complex (Mack & Sninsky, 1988) , primers were extended at their 5' end with sequences containing the BamHI site. The backward primer (GP 18) appeared to be from the region used previously by Manos et al. (1989) to select the MYll primer; the forward primer (GP17) is about 624 to 660 nucleotides upstream of this region. The general properties of the primers and probe were analysed using a panel of representative HPVs isolated from different anatomical sites . Cloned HPV DNA (1 ng) was subjected to PCR in a total volume of 50 ~tl containing 50 mM-KC1, 10 mM-Tris-HC1 pH 8-3, 1-75 mM-MgC12, 0.001 ~o (w/v) gelatin, 200 mM of each dNTP, 1 unit Ampli-Taq DNA polymerase (Cetus) and 50 pmol of primers GP 17 and GP 18. Forty cycles of amplification were performed as described previously (Snijders et al., 1990) except that the annealing temperature was 52 °C. The resulting PCR products, visualized after electrophoresis on a 1.5~ agarose gel, are shown in Fig. 2(a) . Except for the HPV-16 and HPV-30 clones, all the HPV clones examined were successfully amplified resulting in a PCR product ranging in size from about 600 to 700 bp. For pHPV-16 (Seedorf et al., 1985) and pHPV-30 (Kahn et al., 1986 ) the primers flank the cloning site and therefore a 600 to 700 bp HPV-specific DNA fragment was not amplified. This was confirmed by further analysis which revealed that HPV-16 and HPV-30 DNA in clinical specimens and HPV-16 DNA in cervical cell lines were amplified successfully (Fig. 4) . The specificity and generality was confirmed by the fact that no amplification signal was obtained with pBR322 vector DNA, whereas with BPV-1, which shows two mismatches with GP17 and three mismatches with GP18, a weak amplification signal was obtained (Fig. 3 e) . After blotting and hybridization with the 5' end 3zp_ labelled GPR22 probe, the products of all types except HPV-38 and HPV-41 could be detected easily after a 4 h exposure ( Fig. 2b and 3 f for BPV-1). After an overnight exposure a clear hybridization signal also was obtained with HPV 38 and HPV 41 ( Fig. 3c and d) . Therefore, it appeared that the primers and probe amplify and detect sequences from HPVs found mainly in skin lesions , oral mucosa (HPV-13 and -32), genital mucosa , and in both mucosal and cutaneous lesions (HPV-2a and -57). These include both so-called oncogenic and non-oncogenic HPV types. The successful application to HPV-38, isolated from a malignant melanoma (Scheurlen et al., 1986) , and HPV-41, a distantly related type that shows little homology with other isolated types (Grimmel et al., 1988) , is also striking. Moreover, it is worth noting that despite the presence of mismatches with both primers BPV-1 DNA could be amplified. This finding is of importance if we assume that putative, unknown HPV types could be related more closely to the animal PVs than to other HPVs.
The sensitivity of the method was determined by testing serial dilutions of cloned HPV DNA in 100 ng of human placental DNA. On average the sensitivity appeared to be about 7 x l0 s (10 pg pHPV DNA), 7 × 104 (1 pg pHPV DNA) and 7 x 103 (0-1 pg pHPV DNA) viral copies per sample in agarose gels, and after GPR22 hybridization with a 4 h and an overnight exposure, respectively. However, for HPV-38 and HPV-41 DNA the sensitivity appeared to be slightly lower; approximately 7 x 106 (0.1 ng pHPV DNA) and 7 x l0 s viral copies per sample could be detected in agarose gels, and 7 x 104 copies per sample after an overnight exposure for HPV-38 (Fig. 3a and c) and HPV-41 ( Fig.  3b and d) , respectively. These difference between gel and hybridization detection indicate that the amplification step is critical for HPV-38, whereas the hybridization step is less efficient for HPV-41. It can be concluded that the relatively low sensitivity of the method (7 x 103 to 7 x 104 viral copies in 100 ng DNA, depending on the HPV type, after an overnight exposure), which is comparable to genomic Southern blot analysis, is probably due to the high degeneracy of the primers, enhancing annealing to cellular DNA and affecting the efficiency of amPlification of HPV-specific target DNA.
For further analysis of the application of the generalized PCR, the method was used to test 50 to 250 ng DNA from lesions from different sites and cervical scrapes, some of which had previously been found to contain HPV DNA (Snijders et al., 1990) whereas others were suspected to contain HPV D N A owing to the koilocytotic changes observed in histological sections (not shown). DNA from cervical cancer cell lines SiHa (HPV-16), CaSki (HPV-16), C4-1 (HPV-18), and HeLa (HPV-18) was also examined. For most samples an HPV-specific fragment of between 600 and 700 bp was amplified and was visible in agarose gels (Fig. 4a) . The background smears probably reflect the high degeneracy of the primers allowing a certain degree of cross-annealing to cellular DNA. After a 4 h exposure after hybridization to GPR22, all HPV-specific sequences could be detected clearly, whereas no signal appeared with human placental (Hp) DNA (Fig. 4b) . After prolonged exposure of up to 2 days no interfering hybridization signal was obtained with several independent Hp DNA isolates, indicating the high specificity of the combination of the primers and probe. The HPV-positive clinical samples included two skin warts (cul and cu5; cul was found to contain HPV-7 DNA but cu5 has not been typed although it is negative for the common genital HPV types, 6, 11, 16, 18, 31 and 33), a case of Bowen's disease of the hand containing HPV-16 (cu6), two papillomatous laryngeal lesions containing HPV-6 (pl and hi), and cervical scrapes containing HPV-6 (s2), -11 (s4), -16 (s5), -18 (s6), -30 (s7), -31 (s8 and s9) or -33 (s3) DNA.
The sensitivity of this method is comparable with that of genomic Southern blotting, so samples must be selected carefully for the GP17/GP18 primers to be applied reliably. The method can be of value as a first and tissue specimens was extracted as described earlier (Walboomers et al., 1988) . Cervical scrapes were processed as described by van den Brule et al. (1989) . Electrophoretic (a) and GPR22 hybridization analysis (b) are shown. Autoradiography was for 4 h. The clinical samples examined included three cutaneous lesions (cul, cu5 and cu6), two of which were warts (cul and cu5) and one a case of Bowen's disease of the hand (cu6), two papillomatous laryngeal lesions (p 1 and hi) and cervical scrapes (s2 to s9). Lane M, pBR322 DNA digested with HinfI; Hp, human placental DNA.
step to the isolation of new, distantly related HPV types from lesions in which histologically and/or immunohistologically the presence of cytopathological changes (e.g. koilocytosis) and/or late viral capsid antigens can be observed and a productive HPV infection is suspected. This has been substantiated in the skin lesions described (Fig. 4 , samples cul, cu5 and cu6) which fulfil these requirements. Therefore, these 'productive' primers may be useful for the investigation of papillomatous benign and pre-malignant lesions of different organs.
In malignancies, however, other problems may arise, e.g. low HPV copy number per cell and deletion or partial disruption of part of the L 1 0 R F in the primer matched regions caused by integration. In these situations general primers directed against the oncogenic viral regions (i.e. E6 and E 7 0 R F s ) would be more suitable for reliable assessment. These regions, however, are very heterogeneous and primers with the optimal general properties could not be selected. More biological data on the oncogenic character of the E6 and E70RFs, and sequence alterations not affecting the loss of oncogenic potential are necessary to design general oncogenic HPV-detecting primers.
In conclusion, this report has demonstrated that the use of degenerate primers and a probe produced on the basis of amino acid conservation in the PCR has great value in the detection of distantly related HPVs in productively infected tissue, independent of anatomical site.
